Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Somatic mutations of EGFR in colorectal cancers and glioblastomas.

Literature DB >> 15625347

Somatic mutations of EGFR in colorectal cancers and glioblastomas.

Thomas D Barber, Bert Vogelstein, Kenneth W Kinzler, Victor E Velculescu.

Abstract

Entities: Disease Gene Mutation

Mesh：

Substances：

Year: 2004 PMID： 15625347 DOI： 10.1056/NEJM200412303512724

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

94 in total

Review 1. Biomarkers in colorectal cancer.

Authors: B Markman; V Rodríguez-Freixinos; J Tabernero
Journal: Clin Transl Oncol Date: 2010-04 Impact factor: 3.405

Review 2. EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?

Authors: Shailender Singh Kanwar; Jyoti Nautiyal; Adhip P N Majumdar
Journal: Curr Drug Targets Date: 2010-06 Impact factor: 3.465

3. Integrating anti-EGFR therapies in metastatic colorectal cancer.

Authors: Sigurdis Haraldsdottir; Tanios Bekaii-Saab
Journal: J Gastrointest Oncol Date: 2013-09

Review 4. ERBBs in the gastrointestinal tract: recent progress and new perspectives.

Authors: William H Fiske; David Threadgill; Robert J Coffey
Journal: Exp Cell Res Date: 2008-11-07 Impact factor: 3.905

5. KRAS genotyping of paraffin-embedded colorectal cancer tissue in routine diagnostics: comparison of methods and impact of histology.

Authors: Wilko Weichert; Christiane Schewe; Annika Lehmann; Christine Sers; Carsten Denkert; Jan Budczies; Albrecht Stenzinger; Hans Joos; Olfert Landt; Volker Heiser; Christoph Röcken; Manfred Dietel
Journal: J Mol Diagn Date: 2009-12-10 Impact factor: 5.568

6. Analysis of EGFR gene amplification, protein over-expression and tyrosine kinase domain mutation in recurrent glioblastoma.

Authors: Judit Toth; Kristof Egervari; Almos Klekner; Laszlo Bognar; Janos Szanto; Zoltan Nemes; Zoltan Szollosi
Journal: Pathol Oncol Res Date: 2008-08-28 Impact factor: 3.201

Somatic mutations of EGFR in colorectal cancers and glioblastomas.

Review 1. Biomarkers in colorectal cancer.

Review 2. EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?

3. Integrating anti-EGFR therapies in metastatic colorectal cancer.

Review 4. ERBBs in the gastrointestinal tract: recent progress and new perspectives.

5. KRAS genotyping of paraffin-embedded colorectal cancer tissue in routine diagnostics: comparison of methods and impact of histology.

6. Analysis of EGFR gene amplification, protein over-expression and tyrosine kinase domain mutation in recurrent glioblastoma.

Review 7. Mechanisms of tumor resistance to EGFR-targeted therapies.

8. Fine-tuning AKT kinase activity through direct lysine methylation.

9. Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status.

Review 10. EGFR and colon cancer: a clinical view.